| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
68,990,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bicycle Therapeutics is a holding company. Through its subsidiaries, Co. is a clinical-stage biopharmaceutical company developing a class of medicines, which it refers to as Bicycles. Bicycles are a therapeutic modality combining the pharmacology associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Co. is evaluating BT5528, a Bicycle Toxin Conjugate (BTC) targeting Ephrin type-A receptor 2, BT8009, a BTC™ targeting Nectin-4, and BT7480, a Bicycle tumor-targeted immune cell agonist® targeting Nectin-4 and agonizing CD137. In addition, BT1718, a BTC that is being developed to target tumors that express Membrane Type 1 matrix metalloproteinase.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
500,000 |
1,485,397 |
1,485,397 |
| Total Buy Value |
$0 |
$7,670,900 |
$21,230,385 |
$21,230,385 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
2 |
2 |
| Total Shares Sold |
10,959 |
49,396 |
69,448 |
102,916 |
| Total Sell Value |
$84,713 |
$632,891 |
$1,078,063 |
$1,741,478 |
| Total People Sold |
6 |
8 |
9 |
9 |
| Total Sell Transactions |
11 |
26 |
40 |
65 |
| End Date |
2025-03-16 |
2024-12-13 |
2024-06-14 |
2023-06-15 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
• – – |
2025-04-03 |
4 |
S |
$7.48 |
$1,990 |
D/D |
(266) |
54,547 |
|
- |
|
| Lee Kevin |
CHIEF EXECUTIVE OFFICER |
• • – |
2025-04-03 |
4 |
S |
$7.48 |
$25,671 |
D/D |
(3,432) |
486,265 |
|
- |
|
| Milnes Alistair |
CHIEF OPERATING OFFICER |
• – – |
2025-04-03 |
4 |
S |
$7.48 |
$7,764 |
D/D |
(1,038) |
97,617 |
|
- |
|
| Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
• – – |
2025-04-03 |
4 |
S |
$7.48 |
$7,764 |
D/D |
(1,038) |
121,870 |
|
- |
|
| Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
• – – |
2025-04-03 |
4 |
S |
$7.48 |
$815 |
D/D |
(109) |
31,827 |
|
- |
|
| Young Alethia |
Chief Financial Officer |
• – – |
2025-04-02 |
4 |
S |
$8.02 |
$1,724 |
D/D |
(215) |
45,390 |
|
- |
|
| Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
• – – |
2025-04-02 |
4 |
S |
$8.02 |
$3,745 |
D/D |
(467) |
54,813 |
|
- |
|
| Lee Kevin |
CHIEF EXECUTIVE OFFICER |
• • – |
2025-04-02 |
4 |
S |
$8.02 |
$17,941 |
D/D |
(2,237) |
489,697 |
|
- |
|
| Milnes Alistair |
CHIEF OPERATING OFFICER |
• – – |
2025-04-02 |
4 |
S |
$8.02 |
$9,087 |
D/D |
(1,133) |
98,655 |
|
- |
|
| Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
• – – |
2025-04-02 |
4 |
S |
$8.02 |
$6,528 |
D/D |
(814) |
122,908 |
|
- |
|
| Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
• – – |
2025-04-02 |
4 |
S |
$8.02 |
$1,684 |
D/D |
(210) |
31,936 |
|
- |
|
| Westin Eric |
Chief Medical Officer |
• – – |
2025-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,305 |
|
- |
|
| Riva Alessandro |
|
– • – |
2025-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
|
- |
|
| Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
• – – |
2025-01-06 |
4 |
AS |
$15.00 |
$40,290 |
D/D |
(2,686) |
32,146 |
|
- |
|
| Crockett Nigel |
CHIEF BUSINESS OFFICER |
• – – |
2025-01-03 |
4 |
S |
$14.75 |
$13,806 |
D/D |
(936) |
51,053 |
|
- |
|
| Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
• – – |
2025-01-03 |
4 |
S |
$14.75 |
$3,525 |
D/D |
(239) |
55,280 |
|
- |
|
| Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
• – – |
2025-01-03 |
4 |
S |
$14.75 |
$13,806 |
D/D |
(936) |
123,722 |
|
- |
|
| Lee Kevin |
CHIEF EXECUTIVE OFFICER |
• • – |
2025-01-03 |
4 |
S |
$14.75 |
$45,607 |
D/D |
(3,092) |
491,934 |
|
- |
|
| Milnes Alistair |
CHIEF OPERATING OFFICER |
• – – |
2025-01-03 |
4 |
S |
$14.75 |
$13,806 |
D/D |
(936) |
99,788 |
|
- |
|
| Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
• – – |
2025-01-03 |
4 |
AS |
$14.75 |
$2,345 |
D/D |
(159) |
34,832 |
|
- |
|
| Crockett Nigel |
CHIEF BUSINESS OFFICER |
• – – |
2025-01-02 |
4 |
S |
$14.09 |
$36,394 |
D/D |
(2,583) |
51,989 |
|
- |
|
| Crockett Nigel |
CHIEF BUSINESS OFFICER |
• – – |
2025-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
54,572 |
|
- |
|
| Arroyo Santiago |
CHIEF DEVELOPMENT OFFICER |
• – – |
2025-01-02 |
4 |
S |
$14.09 |
$69,647 |
D/D |
(4,943) |
69,057 |
|
- |
|
| Arroyo Santiago |
CHIEF DEVELOPMENT OFFICER |
• – – |
2025-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
74,000 |
|
- |
|
| Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
• – – |
2025-01-02 |
4 |
S |
$14.09 |
$26,475 |
D/D |
(1,879) |
55,519 |
|
- |
|
287 Records found
|
|
Page 1 of 12 |
|
|
